Sanofi
41.60USD
-0.3600 (-0.86%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SNY.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.51▼ | $1.6 | 0 | 2 |
| Next quarter | $1.12▲ | $1.02 | 1 | 1 |
| Current year | $4.9▲ | $4.79 | 0 | 4 |
| Next year | $5.23▲ | $5.14 | 0 | 4 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.14 | $1.2 | +0.06 (+5.6%) |
| 2026-03-31 | $1.03 | $1.1 | +0.07 (+7.3%) |
| 2025-12-31 | $0.85 | $0.91 | +0.06 (+7.4%) |
| 2025-09-30 | $1.57 | $1.69 | +0.13 (+8.1%) |
61 ratings from 26 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Downgraded from Buy | Neutral | — | Jan 16, 2026 |
| Barclays | Downgraded from Overweight | Equal-Weight | — | Jan 6, 2026 |
| Guggenheim | Downgraded from Buy | Neutral | — | Dec 9, 2025 |
| JP Morgan | Downgraded from Overweight | Neutral | — | Dec 8, 2025 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $56 $58 | Sep 8, 2025 |
| Deutsche Bank | Upgraded from Hold | Buy | — | Sep 2, 2025 |
| JP Morgan | Upgraded from Neutral | Overweight | — | Aug 8, 2025 |
| Goldman Sachs | Initiated | Neutral | $65 | Mar 21, 2025 |
| Argus Research | Maintained | Buy | $55 $60 | Jul 26, 2024 |
| Morgan Stanley | Initiated | Equal-Weight | $55 | Jan 23, 2024 |
| Argus Research | Maintained | Buy | $55 $60 | Mar 27, 2023 |
| Deutsche Bank | Upgraded from Sell | Hold | — | Aug 12, 2022 |
| SVB Leerink | Upgraded from Market Perform | Outperform | — | Sep 27, 2021 |
| Deutsche Bank | Initiated | Sell | — | Jan 15, 2021 |
| Goldman Sachs | Upgraded from Neutral | Buy | — | Mar 11, 2020 |
| Argus Research | Maintained | Buy | $52 $56 | Feb 19, 2020 |
| SVB Leerink | Initiated | Market Perform | — | Feb 11, 2020 |
| JP Morgan | Upgraded from Neutral | Overweight | — | Jan 6, 2020 |
| Barclays | Downgraded from Equal-Weight | Underweight | — | Dec 6, 2019 |
| Guggenheim | Upgraded from Neutral | Buy | — | Sep 23, 2019 |
| Bernstein | Initiated | Outperform | $52 | Sep 3, 2019 |
| Morgan Stanley | Initiated | Equal-Weight | — | Dec 14, 2018 |
| Argus Research | Maintained | Buy | $48 $50 | Nov 8, 2018 |
| Barclays | Upgraded from Underweight | Equal-Weight | — | Nov 1, 2018 |
| B of A Securities | Upgraded from Neutral | Buy | — | Sep 10, 2018 |
No analyst notes on SNY yet.
Members whose judged calls on SNY have played out most reliably.
No settled calls on SNY yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
9 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 5 | 6 | 0 | 0 | Hold2.55 |
| 1 mo ago | 0 | 5 | 5 | 0 | 0 | Hold2.50 |
| 2 mo ago | 1 | 4 | 5 | 0 | 0 | Buy2.40 |
| 3 mo ago | 0 | 5 | 5 | 0 | 0 | Hold2.50 |